Form 4: Bio-Rad Laboratories CFO Robin Harper Cowie Reports Stock Sales to Cover Taxes on RSU Vesting

Robin Harper Cowie, CFO, Secretary, and Treasurer of Bio-Rad Laboratories, reports the sale of common stock to cover taxes upon the vesting of Restricted Stock Units (RSUs).

Summary

• Robin Harper Cowie, the CFO, Secretary, and Treasurer of BIODESIX INC, filed a Form 4 detailing changes in beneficial ownership.
• On May 9, 2025, Cowie vested 3,157 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of the Issuer's Common Stock.
• To cover taxes upon the vesting of these RSUs, Cowie sold 496 shares of common stock on May 12, 2025, at a weighted average price of $0.3594.
• An additional 496 shares were sold on May 13, 2025, at a weighted average price of $0.3529, also to cover taxes.
• Following these transactions, Cowie directly owns 248,625 shares of common stock and 9,470 RSUs.
• The RSUs vest in sixteen successive quarterly installments from February 8, 2022, subject to continued service with the Issuer.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions for tax purposes, so the sentiment is neutral.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The sale of shares to cover taxes on vested equity is a common practice.

Comparison to Industry Standards

• Similar transactions are regularly reported by executives at comparable companies such as Exact Sciences, Guardant Health, and Natera.
• These companies also use equity compensation and similar tax coverage strategies.

Stakeholder Impact

• The transactions have a minimal impact on shareholders, as they are related to tax obligations on vested equity.

Key Dates

Keywords

Form 4, Beneficial Ownership, Restricted Stock Units, RSU, Common Stock, BIODESIX INC, Cowie, Vesting, Tax Coverage